Kaleido Biosciences, Inc. - Common Stock (NQ:KLDO)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | - |
| Bid (Size) | 0.3003 (2) |
| Ask (Size) | 0.3100 (20) |
| Prev. Close | 0.2900 |
| Today's Range | N/A - N/A |
| 52wk Range | N/A - N/A |
| Shares Outstanding | 42,622,559 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
Stocks That Hit 52-Week Lows On Friday ↗
April 08, 2022
Why Is Creatd (CRTD) Stock Up Today? ↗
April 13, 2022
Dear KLDO Stock Fans, Mark Your Calendars for April 28 ↗
April 13, 2022
Stocks That Hit 52-Week Lows On Friday ↗
February 04, 2022
12 Health Care Stocks Moving In Friday's Intraday Session ↗
April 08, 2022
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
February 25, 2022
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
January 18, 2022
12 Health Care Stocks Moving In Friday's Intraday Session ↗
December 31, 2021
Stocks That Hit 52-Week Lows On Thursday ↗
February 03, 2022
52 Weeks High And Low Article ↗
January 11, 2022
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
December 30, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
December 16, 2021
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
November 15, 2021
Frequently Asked Questions
Is Kaleido Biosciences, Inc. - Common Stock publicly traded?
Yes, Kaleido Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Kaleido Biosciences, Inc. - Common Stock trade on?
Kaleido Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kaleido Biosciences, Inc. - Common Stock?
The ticker symbol for Kaleido Biosciences, Inc. - Common Stock is KLDO on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
